Skip to main content

Pregabalin

NDC 65862-765 · Aurobindo Pharma Limited

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength300 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

65862-765-05 — 500 CAPSULE in 1 BOTTLE (65862-765-05)

65862-765-78 — 10 BLISTER PACK in 1 CARTON (65862-765-78) / 10 CAPSULE in 1 BLISTER PACK (65862-765-10)

65862-765-90 — 90 CAPSULE in 1 BOTTLE (65862-765-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

64980-415 — PREGABALIN, 64980-416 — PREGABALIN, 64980-417 — PREGABALIN, 65862-758 — Pregabalin, 65862-759 — Pregabalin, 65862-760 — Pregabalin, 65862-761 — Pregabalin, 65862-762 — Pregabalin, 65862-763 — Pregabalin, 65862-764 — Pregabalin, 67046-1494 — Pregabalin, 67046-1628 — Pregabalin, 67046-1680 — Pregabalin, 67877-457 — Pregabalin, 67877-462 — Pregabalin, 67877-463 — Pregabalin, 67877-464 — Pregabalin, 67877-465 — Pregabalin, 67877-466 — Pregabalin, 67877-467 — Pregabalin, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels